GSK’s new antibiotic wins gonorrhea approvalnews2025-12-11T19:19:37+00:00December 11th, 2025|Endpoints News|
Top Trump lawyer calls on SCOTUS to reverse ‘skinny’ generic drug label decisionnews2025-12-11T19:05:07+00:00December 11th, 2025|Endpoints News|
Rhythm reports Imcivree’s key weight loss data from Phase 2 Prader-Willi trialnews2025-12-11T16:17:38+00:00December 11th, 2025|Endpoints News|
House backs Biosecure Act aimed at Chinese companiesnews2025-12-11T09:52:38+00:00December 11th, 2025|Endpoints News|
In a first, FDA approves a gene therapy from a nonprofitnews2025-12-10T16:02:33+00:00December 10th, 2025|Endpoints News|
UK lowers new medicine rebate scheme to 14.5% for 2026news2025-12-10T11:49:17+00:00December 10th, 2025|Endpoints News|
FDA is taking another look at safety of approved RSV antibodiesnews2025-12-09T21:02:59+00:00December 9th, 2025|Endpoints News|
Eli Lilly earmarks $6B for GLP-1 pill factory in Alabamanews2025-12-09T20:30:05+00:00December 9th, 2025|Endpoints News|
#ASH25: New data from Gilead, J&J set up a bispecific, CAR-T rivalrynews2025-12-09T19:17:45+00:00December 9th, 2025|Endpoints News|
#ASH25: Eli Lilly’s Jaypirca makes first-line case, but ceiling may be cappednews2025-12-09T12:30:47+00:00December 9th, 2025|Endpoints News|
